Core and Group Health

With increasing numbers of employees looking to their employers to help support them on their financial journey, it's essential for benefits brokers to leverage this opportunity to enhance the value they provide.

Grail is focusing on early detection and cutting life insurance market sales teams.

After top drugmakers unsuccessfully tried to squash the program, HHS has finally reached agreements with Merck, Novartis and others to lower prices for the first 10 drugs included in the Medicare Drug Price Negotiation Program.

The purchase is subject to bankruptcy court approval, and the transaction will close pending completion of all closing conditions, including regulatory approval.

By utilizing innovative approaches to how care is delivered and monitored through providers, employers can maximize the health and wellness of their employee base while improving health equity.

A company executive suggested that some competitors may have underpriced their coverage.